However, other studies, such as that by Haideri et al., have not found consistent associations between hormone receptor status or HER2 expression and residual tumours, suggesting that these factors may be influenced by additional variables such as tumour size or margin width [37]. This evidence concerns the gene ERBB2 and neoplasm.